Wynne Weston-Davies
Keine laufenden Positionen mehr
Karriereverlauf von Wynne Weston-Davies
Ehemalige bekannte Positionen von Wynne Weston-Davies
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Varleigh Immuno Pharmaceuticals Uk Ltd. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | 01.01.2014 |
Evolutec Group Plc
 Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Volution Immuno Pharmaceuticals SA
 Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | - |
| AKARI THERAPEUTICS, PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2015 | - |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 2 |
| Schweiz | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKARI THERAPEUTICS, PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Volution Immuno Pharmaceuticals SA
Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Health Technology |
| Varleigh Immuno Pharmaceuticals Uk Ltd. | |
Evolutec Group Plc
Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Health Technology |
- Börse
- Insiders
- Wynne Weston-Davies
- Erfahrung
